Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) (RFA-MD-24-006)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) (PA-24-141)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Use of Digital Technology and Mobile Health to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome (NOT-OD-24-044)

Sponsor: National Institutes of Health

Due Date: This notice applies to due dates through February 14, 2025.

Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed) (PAR-24-108)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Application budgets are not limited, but need to reflect the actual needs of the proposed project.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed) (RFA-MH-25-100)

Sponsor: National Institutes of Health

Award: NIH intends to commit an estimated total of $14,000,000 per year to fund 4 to 6 awards.

Due Date: June 14, 2024 and January 17, 2025. (LOI due 30 days before application due date.)

BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed) (RFA-MH-25-105)

Sponsor: National Institutes of Health

Award: NIH intends to commit an estimated total of $2,400,000 per year to fund 2 to 4 awards.

Due Date: October 31, 2025 and July 01, 2026. LOI due 30 days prior to the application due date(s).

Translational Neural Devices (R61/R33 - Clinical Trial Optional) (PAR-24-151)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in AD and ADRD (NOT-AG-23-054)

Sponsor: National Institute on Aging

Due Date: June 10, 2024 (LOI due April 15, 2024) and December 9, 2024 (LOI due October 15, 2024).

NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (UE5 - Clinical Trial Not Allowed) (PAR-24-079)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) (RFA-MH-25-170)

Sponsor: National Institutes of Health

Award: NIH BRAIN and partner components intend to commit an estimated total of $3M in fiscal years 2025, 2026, 2027 to fund up to 8 new awards, each year, contingent upon annual appropriations. Application budgets are limited to $300,000 in direct costs in any project year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) (RFA-MH-25-171)

Sponsor: National Institutes of Health

Award: NIH BRAIN and partner components intend to commit an estimated total of $2M in fiscal years 2025, 2026, 2027 to fund up to 8 new awards each year for this RFA, contingent upon annual appropriations. The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: Multiple due dates; see announcement.

NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) (RFA-NS-24-030)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Dorothy Dillon Eweson Lecture Series

Sponsor: American Federation for Aging Research (AFAR)

Award: Provides selected applicants with funding up to a maximum of $2,000 to cover travel expenses and meeting-related fees.

Due Date: Applications are accepted on a rolling basis.

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) (PAR-24-095)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) (PAR-24-096)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: Budgets up to $700,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested.

Due Date: Multiple due dates; see announcement.